SEC Company Response from SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478) (SLS) — Jun 28, 2018
SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478)
Date: June 28, 2018 · CIK: 0001390478 · Accession: 0001193125-18-207511
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225140
Letter
Re: Sellas Life Sciences Group, Inc.
June 28, 2018
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Irene Paik
Registration Statement on Form S-1
File No. 333-225140
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on June 26, 2018, in which we requested the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-225140) to Wednesday, June 27, 2018, at 4:30 p.m., Eastern Time (which was later changed orally to Thursday, June 28, 2018 at 4:30 p.m., Eastern Daylight Time), in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date thereof.
Please note that we intent to file as correspondence a new acceleration request tomorrow morning requesting the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-225140) to Monday, July 2, 2018, at 9:00 a.m., Eastern Time.
Very truly yours,
Sellas Life Sciences Group, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 28, 2018 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Irene Paik Re: Sellas Life Sciences Group, Inc. Registration Statement on Form S-1 File No. 333-225140 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on June 26, 2018, in which we requested the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-225140) to Wednesday, June 27, 2018, at 4:30 p.m., Eastern Time (which was later changed orally to Thursday, June 28, 2018 at 4:30 p.m., Eastern Daylight Time), in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date thereof. Please note that we intent to file as correspondence a new acceleration request tomorrow morning requesting the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-225140) to Monday, July 2, 2018, at 9:00 a.m., Eastern Time. Very truly yours, Sellas Life Sciences Group, Inc. By: /s/ Barbara A. Wood Barbara A. Wood Executive Vice President, General Counsel and Corporate Secretary cc: Yvan-Claude Pierre, Cooley LLP